4-(Chloromethyl)-2-(Thiophen-2-Yl)-1,3-Thiazole

High-purity 4-(Chloromethyl)-2-(thiophen-2-yl)-1,3-thiazole is stored under inert gas with moisture content maintained below 0.03% (Karl Fischer titration per USP <921> Method Ic). The chloromethyl moiety undergoes rapid hydrolysis in the presence of water, generating a hydroxymethyl byproduct that complicates downstream crystallization. For this reason, receiving vessels and feed lines on production-scale reaction trains are purged with dry nitrogen of dew point ≤ -40 °C before charging, and inline FTIR probes monitor the disappearance of the C-Cl stretching band at 725 cm⁻¹ to track conversion in real time.

What governs regioselectivity during nucleophilic displacement at the 4-chloromethyl position in anhydrous API intermediate synthesis?

The substitution chemistry of the chloromethyl group on this thiophene-thiazole scaffold is leveraged in the preparation of kinase inhibitor candidates containing a 2-(thiophen-2-yl)thiazole pharmacophore. In a typical late-stage coupling sequence, the compound is reacted with the nitrogen of a substituted piperazine or piperidine in tetrahydrofuran at −10 °C to 0 °C in the presence of potassium carbonate (1.2 equivalents) and a catalytic quantity of tetrabutylammonium iodide (0.05 eq). The reagent stoichiometry is kept within 1.00–1.05 molar equivalents of the amine to minimize dialkylation at the thiophene α-position, which has been observed to compete when the amine is present in excess above 1.10 eq. Reaction progress is monitored by UPLC with UV detection at 290 nm; the target N-alkylated intermediate typically elutes at a relative retention time of 1.34 against the starting chloromethyl compound. After aqueous work-up and vacuum distillation of the solvent, the crude oil is crystallized from n-heptane/ethyl acetate (4:1 v/v) to yield a white crystalline solid with an HPLC purity exceeding 99.2 area%. On a 500 L glass-lined reactor equipped with a retreat-curve impeller, shear rates below 150 rpm have been shown to create localized gradients of residual water, driving hydrolytic impurity formation from typically <0.10% to as high as 0.48% across a campaign of 12 batches. The resulting hydroxymethyl impurity is flagged under ICH M7(R2) as a Class 3 monofunctional alkylating agent with an acceptable intake of 1.5 mg/day, necessitating control at the final API stage to levels below 0.15% by LC-MS/MS. Residual solvent limits comply with ICH Q3C(R8); THF is limited to 720 ppm and n-heptane to 5000 ppm. The final drug substance, formulated as a hydrochloride salt, is processed into 25 mg and 100 mg immediate-release film-coated tablets for oral administration under 21 CFR 211 cGMP conditions.

In agrochemical synthesis, incorporation of the thiophen-2-yl-thiazole core into succinate dehydrogenase inhibitor (SDHI) fungicides proceeds through a palladium-catalyzed Suzuki-Miyaura coupling between the chloromethyl-substituted thiazole and a commercially available 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline derivative. The cross-coupling is executed in a 2000 L stirred reactor containing degassed toluene and 2 M aqueous sodium carbonate under a nitrogen blanket, using Pd(dppf)Cl₂·CH₂Cl₂ at a catalytic loading of 0.8 mol% relative to the boronic ester. The thiazole intermediate is charged at 1.00 molar equivalent, and the coupling partner is added in 5% molar excess to compensate for protodeboronation losses that are accelerated at reaction temperatures above 60 °C. After phase separation and filtration through a plug of Celite, the coupled biaryl intermediate is cyclized with thiophosgene at 5–10 °C to install a thiazolidinone ring, generating the active ingredient 2-(4-(2-(thiophen-2-yl)thiazol-4-yl)methyl)phenyl)-3-thiazolidinone. The technical-grade active is milled in a fluidized-bed opposed-jet mill to a median particle size (D₅₀) of 2.0–3.5 µm and formulated as a 250 g/L suspension concentrate (SC) using a block copolymer dispersant at 4.5 wt% on active. Field trial reports from application rates of 200–300 g a.i./ha indicate control of Fusarium head blight comparable to prothioconazole references. Regulatory support documentation references CIPAC MT 46.3 for suspensibility, MT 184 for wet sieve residue, and OECD 106 adsorption/desorption batch equilibrium for environmental fate. The manufacturing process and impurity profile are registered under EPA OPPTS 830.1800 guidelines, and the five-batch analysis confirms the absence of the des-chloro dimer impurity at a reporting threshold of 0.05%.

When a thiophene-thiazole monomer is copolymerized into a donor-acceptor backbone at loadings exceeding 30 mol%, a solubility cliff triggers the requirement for heated slot-die coating

The electron-deficient thiazole ring of the monomer imparts a deep highest occupied molecular orbital (HOMO) energy level of −5.52 eV when incorporated into alternating copolymers with benzodithiophene-based donor units, as measured by photoelectron spectroscopy in air (PESA). Copolymerization is performed via Stille polycondensation in anhydrous chlorobenzene at a monomer concentration of 0.15 M using Pd₂(dba)₃ (2 mol%) and tri(o-tolyl)phosphine (8 mol%). The chloromethyl substituent remains intact, serving as a latent crosslinkable site for subsequent solid-state thermal annealing; crosslinking onset occurs at 165 °C by DSC with an exothermic enthalpy of 48 J/g. When the thiazole monomer fraction reaches 35 mol%, the weight-average molecular weight (Mw) drops from 42 kDa to 28 kDa (GPC vs. polystyrene standards in 1,2,4-trichlorobenzene at 150 °C) due to competitive catalyst poisoning by the thienyl sulfur. The polymer is purified by Soxhlet extraction sequentially with methanol, acetone, and hexane, then dissolved in o-dichlorobenzene at 85 °C and filtered through a 0.45 µm PTFE syringe filter. Processing of the active layer on a roll-to-roll slot-die coater requires the coating head and solution reservoir to be jacketed and held at 85 ± 2 °C; deviation below this window results in gel particle formation that is visible as comets in the dried film under dark-field microscopy, while exceeding 90 °C initiates premature crosslinking that raises the film roughness RMS from 1.2 nm to 4.7 nm (AFM 5 µm × 5 µm scan). The dried active layer is thermally annealed in a glovebox at 175 °C for 10 minutes to induce crosslinking and lock the morphology. Finished devices in an inverted ITO/ZnO/active/MoOₓ/Ag architecture deliver a power conversion efficiency of 8.1% under AM 1.5G illumination at 1000 W/m², with less than 5% efficiency burn-in loss after 1000 hours of continuous light soaking at maximum power point tracking at 45 °C. All materials processed for organic photovoltaic modules conform to IEC 61215-1:2021 for design qualification and IEC 62930:2017 for insulation requirements; the monomer is specified with total palladium content <0.5 ppm to prevent shunt paths in large-area modules.

Parallel library synthesis in drug discovery contract research routinely exploits the chloromethyl functionality for late-stage diversification via nucleophilic displacement with primary and secondary amines. An automated liquid handler dispenses a 0.1 M solution of 4-(chloromethyl)-2-(thiophen-2-yl)-1,3-thiazole in 1,2-dichloroethane into 96-well plates containing pre-weighed amine sub-milligram aliquots and anhydrous potassium carbonate. Each well receives 100 µL (0.01 mmol, 1.0 equivalent) of the thiazole stock solution plus 1.2 equivalents of the amine. The plates are sealed with PTFE-lined caps and heated at 50 °C for 6 hours on an orbital shaker at 300 rpm. Upon cooling, the reaction mixtures are filtered through 0.2 µm PTFE frits into collection plates, evaporated under a stream of dry nitrogen, and reconstituted in DMSO-d6 for automated NMR acquisition on a 600 MHz spectrometer equipped with a cryoprobe. A typical screen of 384 compounds yields a success rate of 78% (defined by >85% conversion by LC-ELSD), with the prevalent failure mode being hydrolysis in wells where moisture penetration occurred during storage of the amine set. The compound library is registered in a corporate database with attendant CheMBL-style bioactivity annotations and shipped as 10 mM DMSO stock solutions in 96-tube matrix racks to screening partners under ISO 9001:2015 quality management. No pharmacopoeial monograph applies; the provided certificate of analysis references ASTM E1172-17 for the reporting of purity by area normalization.

Minimizing dimerization byproducts in continuous-flow thioether synthesis

Reaction of 4-(chloromethyl)-2-(thiophen-2-yl)-1,3-thiazole with aliphatic and aromatic thiols to form thioether-linked intermediates is subjected to continuous-flow processing to suppress the formation of a symmetric sulfide dimer generated via intermolecular self-condensation. In batch mode at 80 °C in dimethylformamide with triethylamine as base, dimer content accounts for 4–7 area% of the crude product; shifting to a PFA tubular flow reactor with an internal diameter of 0.8 mm and a residence time of 90 seconds at 65 °C reduces the dimer byproduct to <0.3 area%. The optimal feed stream consists of a 0.45 M solution of the chloromethyl thiazole in acetonitrile and a separate stream of the thiol (1.05 equivalents) with 1.10 equivalents of triethylamine premixed in acetonitrile, combined at a T-mixer at a total flow rate of 1.2 mL/min. A back-pressure regulator set at 7 barg prevents boiling and ensures stable slug flow. The output stream is quenched inline with 0.5 M aqueous citric acid, separated in a membrane phase separator, and concentrated under reduced pressure. Thioether products are isolated as pale yellow oils with GC purity of 98.5–99.2%. These intermediates serve as precursors to aryl sulfone and sulfoxide derivatives used in liquid-crystal display (LCD) alignment-layer additives and in specialty epoxy hardeners for underfill encapsulants. Compliance with EU REACH requires registration of the manufactured substance for the tonnage band 1–10 tonnes/year; an environmental safety assessment following ECHA Guidance R.8 and a DNEL derivation for workers handling the neat thioether are included in the technical dossier. The finished formulated product containing the sulfone derivative is applied in a 0.2–0.5 wt% loading within a UV-curable epoxy matrix, and the alignment layer is tested for voltage holding ratio per IEC 61747-5-3:2015.

Electrophilic metalation at the thiophene α-position of the intact thiazole compound allows regioselective halogen dance and subsequent cross-coupling without disturbing the chloromethyl handle. Treatment with lithium diisopropylamide at −78 °C in THF generates the α‑lithiated species, which is quenched with iodine to yield 4-(chloromethyl)-2-(5-iodothiophen-2-yl)-1,3-thiazole in 87% isolated yield. This iodinated intermediate undergoes Negishi coupling with organozinc reagents derived from aryl bromides in the presence of Pd-PEPPSI-IPr catalyst (1 mol%) at 40 °C to furnish a library of biaryl‑thiazole‑thiophene hybrids for biological target engagement studies. A biotech company operating under 21 CFR 58 Good Laboratory Practice for nonclinical studies has utilized 150 g batches of the chloromethyl starting material to produce 22 g of a selective serotonin receptor modulator candidate after a 7-step linear synthesis, with the chloromethyl group eventually converted to a morpholinomethyl substituent in the penultimate step. Scale-up to 500 g input in a 20 L jacketed reactor required strict moisture exclusion (≤ 5 ppm water in THF) to prevent lithium‑hydrogen exchange competition, and the resulting iodo intermediate was telescoped without chromatography by crystallization from toluene/cyclohexane, meeting a specification of ≥ 96% assay by qNMR with 1,2,4,5-tetrachloro-3-nitrobenzene as internal standard. The final compound is stored as a lyophilized powder in amber vials under argon at −20 °C for a recommended retest period of 24 months.